Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Mar;41(3):399–406. doi: 10.1038/bjc.1980.63

Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma.

M C Kew, M B Ray, V J Desmet, J Desmyter
PMCID: PMC2010221  PMID: 6248094

Abstract

Formalin-fixed, paraffin-embedded sections of liver and tumour tissue obtained at necropsy from 44 southern African Blacks with hepatocellular carcinoma were stained for hepatitis-B virus surface antigen by immunofluorescence, immunoperoxidase and orcein techniques. The antigen was present in the serum of 68% of the patients. Staining for tissue antigen was positive in 45% of the patients. Non-tumorous hepatocytes alone stained positively in 22.5% of patients, tumour cells alone in 12.5% and both in 10%. Antigen was present in relatively few tumour cells and the amounts detected were small; it was more readily detectable in moderately differentiated than in poorly differentiated malignant cells. Identical results were obtained with immunofluorescence and immunoperoxidase staining, but the orcein stain failed to demonstrate the antigen in tumour cells. Cirrhosis was present in the non-tumorous liver in 70% of the patients. Antigen was detected in cirrhotic tissue in 43% of the patients with cirrhosis, and in non-tumorous liver tissue in 8% of those without cirrhosis, but this difference was not significant. The antigen frequency in tumour tissue was the same in patients with and without cirrhosis. No correlation was found between the presence of liver-cell dysplasia and the presence or absence of either the antigen or cirrhosis in the non-tumorous liver tissue. Ground-glass hepatocytes were seen in non-tumorous liver tissue of 5 patients, but not in tumour tissue. While 54% of the patients with antigenaemia had demonstrable tissue antigen, 10% of patients with tissue antigen had no detectable antigenaemia.

Full text

PDF
399

Images in this article

403Fig. 1
on p.403
403Fig. 2
on p.403
404Fig. 3
on p.404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony P. P., Vogel C. L., Barker L. F. Liver cell dysplasia: a premalignant condition. J Clin Pathol. 1973 Mar;26(3):217–223. [PMC free article] [PubMed] [Google Scholar]
  2. Burns J. Immunoperoxidase localisation of hepatitis B antigen (HB) in formalin-paraffin processed liver tissue. Histochemistry. 1975 Jul 30;44(2):133–135. doi: 10.1007/BF00494074. [DOI] [PubMed] [Google Scholar]
  3. Busachi C. A., Ray M. B., Desmet V. J. An immunoperoxidase technique for demonstrating membrane localized HBsAg in paraffin sections of liver biopsies. J Immunol Methods. 1978;19(1):95–99. doi: 10.1016/0022-1759(78)90012-1. [DOI] [PubMed] [Google Scholar]
  4. Cohen C., Berson S. D., Geddes E. W. Hepatitis B antigen in black patients with hepatocellular carcinoma: correlation between orcein stained liver sections and serology. Cancer. 1978 Jan;41(1):245–249. doi: 10.1002/1097-0142(197801)41:1<245::aid-cncr2820410134>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  5. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  6. MacNab G. M., Alexander J. J., Lecatsas G., Bey E. M., Urbanowicz J. M. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer. 1976 Nov;34(5):509–515. doi: 10.1038/bjc.1976.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nayak N. C., Dhar A., Sachdeva R., Mittal A., Seth H. N., Sudarsanam D., Reddy B., Wagholikar U. L., Reddy C. R. Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int J Cancer. 1977 Nov 15;20(5):643–654. doi: 10.1002/ijc.2910200502. [DOI] [PubMed] [Google Scholar]
  8. Prince A. M., Brotman B., Jass D., Ikram H. Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet. 1973 Jun 16;1(7816):1346–1350. doi: 10.1016/s0140-6736(73)91674-7. [DOI] [PubMed] [Google Scholar]
  9. Ray M. B., Desmet V. J., Bradburne A. F., Desmyter J., Fevery J., De Groote J. Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology. 1976 Sep;71(3):462–469. [PubMed] [Google Scholar]
  10. Ray M. B., Desmet V. J. Immunofluorescent detection of hepatitis B antigen in paraffin-embedded liver tissue. J Immunol Methods. 1975 Jan;6(3):283–289. doi: 10.1016/0022-1759(75)90071-x. [DOI] [PubMed] [Google Scholar]
  11. Ray M. B., van Damme B., Desmet V. J. Evaluation of a modified fluorescent technique for the detection of Australia antigen in liver tissue. J Immunol Methods. 1974 Jan;3(1):47–52. doi: 10.1016/0022-1759(74)90032-5. [DOI] [PubMed] [Google Scholar]
  12. Shikata T., Uzawa T., Yoshiwara N., Akatsuka T., Yamazaki S. Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies. Jpn J Exp Med. 1974 Feb;44(1):25–36. [PubMed] [Google Scholar]
  13. Sumithran E., Prathap K. HBAg-positive chronic liver disease associated with cirrhosis and hepatocellular carcinoma in the Senoi. Cancer. 1977 Oct;40(4):1618–1620. doi: 10.1002/1097-0142(197710)40:4<1618::aid-cncr2820400434>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  14. Tan A. Y., Law C. H., Lee Y. S. Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma. Pathology. 1977 Jan;9(1):57–64. doi: 10.3109/00313027709085239. [DOI] [PubMed] [Google Scholar]
  15. Trevisan A., Realdi G., Losi C., Ninfo V., Rugge M., Rampinelli L. Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue. J Clin Pathol. 1978 Dec;31(12):1133–1139. doi: 10.1136/jcp.31.12.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Turbitt M. L., Patrick R. S., Goudie R. B., Buchanan W. M. Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma. J Clin Pathol. 1977 Dec;30(12):1124–1128. doi: 10.1136/jcp.30.12.1124. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES